• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
PDN
Click for more information
1.90% $11.77

PALADIN ENERGY LTD - Corporate Spotlight

Market Cap $3.520B  ! watchlist Created with Sketch. Add to my watchlist
Energy

Paladin Energy Ltd is an Australia-based independent uranium producer with a 75%... Paladin Energy Ltd is an Australia-based independent uranium producer with a 75% ownership of the world-class long life Langer Heinrich Mine (LHM) located in Namibia. The Company also owns a portfolio of uranium exploration and development assets in Canada and Australia. Its segments include Exploration, Namibia and Australia. The LHM is located in central western Namibia approximately 80 kilometers (km) east of Swakopmund and 85 km northeast of the Walvis Bay major deepwater harbor. Its exploration projects include Michelin, Manyingee and Mount Isa. The Company, through its subsidiary Aurora Energy Ltd, holds a 100% interest in over 98,320 hectares of mineral exploration licenses. These are located within the Central Mineral Belt of Labrador, Canada. It has a 100% interest in the Manyingee Project. This project is a sandstone hosted uranium project consisting of 41 Mlb across two deposits. It wholly-owns a project comprised of three promising uranium exploration sites in Queensland.More

No Corporate Spotlight currently available.

(20min delay)
Last
$11.77 		Change
0.220(1.90%) 		Mkt cap ! $3.520B
Open High Low Value Volume
$11.40 $11.78 $11.39 $24.55M 2.101M

Buyers (Bids)

No. Vol. Price($)
1 4694 $11.75
 

Sellers (Offers)

Price($) Vol. No.
$11.78 4519 4
View Market Depth
Last trade - 16.10pm 01/10/2024 (20 minute delay) ?
Last
$11.77 		  Change
0.220 ( 3.12 %)
Open High Low Volume
$11.40 $11.78 $11.40 370474
Last updated 15.59pm 01/10/2024 ?
PDN (ASX) Chart

Top Stories

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Coda Minerals (ASX:COD) CEO, Chris Stevens, joins The Market Online to discuss the company's current rights issue, and how the capital from this raise will be used to further its copper exploration in South Australia. In addition, Chris talks through the journey the company has taken over the last few years since listing until now.
Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger Recce Pharmaceuticals (ASX:RCE) has been on a tear this year. It's developing anti-infective, R327, with clinical results across Diabetic Foot Infection, Acute Bacterial Skin & Skin Structure Infection, and, Urosepsis/UTIs which point to a potential commercial value proposition. It also has a recent key relationship in Indonesia.
Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals Actinogen Medical is developing a promising oral treatment for Alzheimer's and depression and is accelerating clinical trials with new capital.
Failure to report prompts ASX to impose multiple company suspensions The ASX today told more than 20 companies across many sectors that it would be imposing suspensions on them
Iress runs 'hot' for Wealth Within's stock tips Financial services software play Iress (ASX:IRE) is the HotCopper Hot Stock tip this week from Wealth Within's chief analyst Dale Gillham and senior analyst Fil Tortevski.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.